Skip to main content
. 2022 Mar 17;20:105. doi: 10.1186/s12916-022-02284-6

Fig. 5.

Fig. 5

Relapse-free survival in combined TCGA-BRCA and METABRIC dataset. A ERBB2 CNV based on GISTIC definition in the entire cohort. B ERBB2 CNV neutral vs non-neutral (other) status in the entire cohort. C ERBB2 CNV neutral vs non-neutral status in hormone receptor-positive subgroup. D ERBB2 CNV neutral vs non-neutral status in hormone receptor-negative subgroup